Eisai
4523.T
#1936
Rank
C$11.67 B
Marketcap
$41.43
Share price
-0.23%
Change (1 day)
-29.99%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $2.95

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.15. In 2022 the company made an earnings per share (EPS) of $2.31 a decrease over its 2021 EPS that were of $10.27.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.9527.51%
2022$2.31-77.48%
2021$10.27-41.88%
2020$17.66-0.94%
2019$17.8352.59%
2018$11.68124.17%
2017$5.21-49.42%
2016$10.3137.08%
2015$7.52-11.75%
2014$8.52-3.23%
2013$8.80-18.56%
2012$10.81-15.51%
2011$12.80-3.75%
2010$13.29-1.36%
2009$13.48